MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Tozadenant phase 3 study (TOZ-PD) in Parkinson’s disease patients with motor fluctuations: baseline characteristics

    K. Kieburtz, W. Olanow, J. Krishnaswami, C. Resburg, F. Kerwood, C. Kenney (Rochester, NY, USA)

    Objective: To describe the baseline characteristics of the TOZ-PD study population. Background: Tozadenant is an adenosine A2A antagonist under investigation as an adjunct to levodopa…
  • 2017 International Congress

    Evaluation of Brainstem Auditory Evoked Response and Nerve Conduction in Parkinson’s Disease

    D. AGRAWAL, N. AHMED, A. CHUGHTAI (ALIGARH-202002, India)

    Objective: The Aim of our study was to evaluate Nerve Conduction Velocity & Brainstem Auditory Evoked Response in patients with Parkinson’s disease. Background: Parkinson’s disease is a progressive…
  • 2017 International Congress

    Utility of susceptibility weighted imaging in the objective diagnosis of idiopathic Parkinson’s Disease: Is DaTscan necessary?

    R. Ellis, M. Radon, M. Bonello, M. Steiger (Liverpool, United Kingdom)

    Objective: To assess the utility of susceptibility weighted imaging (SWI) in the diagnosis of idiopathic Parkinson’s Disease (IPD) from the movement disorders clinics at the…
  • 2017 International Congress

    Hippocampal iron deposition in Parkinson disease and Parkinson disease with dementia/Lewy body dementia: quantitative susceptibility mapping assessments

    M. Miyata, S. Kakeda, J. Moriya, H. Narimatsu, T. Sato, H. Adachi, Y. Wang, Y. Korogi (Kitakyushu, Japan)

    Objective: We compared quantitative susceptibility mapping (QSM) values in the hippocampi among patients with Parkinson disease (PD) and PD with dementia (PDD)/ Lewy body dementia…
  • 2017 International Congress

    Sexual Dysfunction in Women with Parkinson’s Disease

    A. Hannoun, E. Adams, K. Smith, N. Cohen, A. Deb (Worcester, MA, USA)

    Objective: To assess the prevalence and significance of sexual dysfunction (SD) in women with Parkinson’s Disease (PD) in comparison to general population, highlight the specific…
  • 2017 International Congress

    Compulsive sexual behaviour in Parkinson’s disease is associated with higher doses of levodopa

    P. Barbosa, T. Warner, A. Djamshidian (London, United Kingdom)

    Objective: To assess whether compulsive sexual behaviour in individuals with PD is associated with higher doses of levodopa.  Background: The lifetime prevalence of compulsive sexual behaviour…
  • 2017 International Congress

    Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.

    E. Aluckal (Ernakulam, India)

    Objective: The objective of the present study was to evaluate the oral health-related quality of life among patients and their caregivers with Parkinson's disease. Background: Parkinson's disease can severely…
  • 2017 International Congress

    Sex Differences in Homebound Advanced Parkinson’s Disease Patients

    L. Nwabuobi, W. Barbosa, M. Sweeney, S. Oyler, A. Lemen, T. Meisel, A. Di Rocco, J. Chodosh, J. Fleisher (New York, NY, USA)

    Objective: To describe sex differences in homebound patients with advanced Parkinson’s disease and related disorders in an interdisciplinary home visit program (HVP) Background: It has…
  • 2017 International Congress

    An association between impulse control disorders and dopamine agonists in Japanese patients with Parkinson’s disease.

    Y. Yamanishi, R. Ando, C. Yamasaki, S. Tada, N. Miyaue, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, M. Nomoto (Ehime, Japan)

    Objective: To evaluate an association between impulse control disorders (ICDs) and dopamine agonists (DA) therapy in Japanese patients with Parkinson’s disease (PD). Background: ICDs such…
  • 2017 International Congress

    A double-blind, randomized, placebo controlled study of botulinum toxin type A for limb pain in advanced Parkinson’s disease

    V. Bruno, M. Freitas, D. Mancini, J. Liu, J. Miyasaki, S. Fox (CABA, Argentina)

    Objective: To evaluate safety, tolerability and efficacy of botulinum toxin type A for limb pain in advanced Parkinson´s disease (PD). Background: Pain is a frequent…
  • « Previous Page
  • 1
  • …
  • 286
  • 287
  • 288
  • 289
  • 290
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley